play-unbranded
Pharma Launch Secrets
Peer-to-Peer Programs and Pharma Launches: Opportunities to Engage HCPs Using Short-Form, Trusted, Clinically Relevant Information with Andrew Willmer, EVP of Strategy and Innovation at Symbiotix
Peer-to-Peer Programs and Pharma Launches: Opportunities to Engage HCPs Using Short-Form, Trusted, Clinically Relevant Information with Andrew Willmer, EVP of Strategy and Innovation at Symbiotix
EP 9
00:00/00:00
Never miss an episode
September 28, 2022
Peer-to-Peer Programs and Pharma Launche...

Peer-to-peer programs bring together clinical experts from the same field to share information and expertise on a specific pharma subject. Lately, there has emerged a high demand for clinically experienced doctors and experts to discuss with their peers and give advice to each other. In this episode of Pharma Launch Secrets, Bozidar is joined by Andrew Willmer, EVP of Strategy and Innovation at Symbiotix.

Share this episode

Embed this episode